Bixing Zhao

2.6k total citations
62 papers, 1.5k citations indexed

About

Bixing Zhao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bixing Zhao has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 17 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Bixing Zhao's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (8 papers). Bixing Zhao is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (8 papers). Bixing Zhao collaborates with scholars based in China, United States and Switzerland. Bixing Zhao's co-authors include Xiaolong Liu, Jingfeng Liu, Yue Wu, Yingchao Wang, Naishun Liao, Youshi Zheng, Yongyi Zeng, Wenxiu Zhao, Ming Wu and Qiao Wu and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Bixing Zhao

57 papers receiving 1.5k citations

Peers

Countries citing papers authored by Bixing Zhao

Since Specialization

Citations

This map shows the geographic impact of Bixing Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bixing Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bixing Zhao more than expected).

Fields of papers citing papers by Bixing Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bixing Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bixing Zhao. The network helps show where Bixing Zhao may publish in the future.

Co-authorship network of co-authors of Bixing Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Bixing Zhao. A scholar is included among the top collaborators of Bixing Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bixing Zhao. Bixing Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET 2025 ·Cell Death and Disease ·(unknown), Bin Zheng, (unknown), (unknown), (unknown), (unknown), (unknown), Guobing Xu, Bixing Zhao, Xiaolong Liu, Yingchao Wang, Yang Zhang, Chun Chen	0
2	Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression 2025 ·Frontiers in Immunology ·(unknown), Fei Wang, (unknown), Yingying Li, Jui‐Hung Weng, (unknown), Liqiong Cai, (unknown), Bixing Zhao, Yongyi Zeng	2
3	CRISPR/Cas12b assisted loop-mediated isothermal amplification for easy, rapid and sensitive quantification of chronic HBV DNA in one-pot 2024 ·Analytica Chimica Acta ·Haipo Xu, (unknown), Ronghua Chen, Zhixiong Cai, Yupeng Sun, Xiaolong Zhang, Bixing Zhao, Yongyi Zeng, Jingfeng Liu, Xiaolong Liu	14
4	Lnc-PIK3R1, transcriptionally suppressed by YY1, inhibits hepatocellular carcinoma progression via the Lnc-PIK3R1/miR-1286/GSK3β axis 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Peng Lyu, (unknown), Runzhi Deng, Qiliang Wei, (unknown), Lei Cheng, Bixing Zhao, Zhonglei Lu	2
5	Reduced glutathione enhances adipose tissue‐derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway 2024 ·Bioengineering & Translational Medicine ·(unknown), Yingchao Wang, Yingjun Shi, (unknown), Bixing Zhao, Naishun Liao, Xiaolong Liu	0
6	RNA Methyltransferase FTSJ3 Regulates the Type I Interferon Pathway to Promote Hepatocellular Carcinoma Immune Evasion 2023 ·Cancer Research ·Qiuyu Zhuang, (unknown), Xuechun Xu, (unknown), (unknown), Youshi Zheng, Xiaohua Xing, (unknown), Yingchao Wang, (unknown), Bixing Zhao, Yongyi Zeng, Xiaolong Liu	11
7	Hsa_circ_0001687 Function as a ceRNA to Facilitate HepatocellularCarcinoma Progression via miR-140- 3p/FOXQ1 Axis 2023 ·Protein and Peptide Letters ·You Song, (unknown), Fei Wang, (unknown), Yingchao Wang, Bixing Zhao, Jingfeng Liu, (unknown)	0
8	Universal two‐dimensional labelled probe‐mediated melting curve analysis based on multiplex PCR for rapid typing of Plasmodium in a single closed tube 2023 ·Microbial Biotechnology ·Haipo Xu, Yupeng Sun, Xiaolong Zhang, Ronghua Chen, Zhixiong Cai, Bixing Zhao, Xiaolong Liu, Jingfeng Liu	3
9	Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1α/METTL16/lnc-CSMD1-7/RBFOX2 axis 2023 ·iScience ·Yingchao Wang, Yong Yang, (unknown), Yuan Dang, (unknown), Qiuyu Zhuang, Xiaoyuan Zheng, Fei Wang, (unknown), Xiaolong Liu, (unknown), Bixing Zhao	20
10	ADAR1-Mediated RNA Editing and Its Role in Cancer 2022 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), Fei Wang, (unknown), Jingfeng Liu, Bixing Zhao	31
11	Long non-coding RNA COX7C-5 promotes hepatocellular carcinoma progression via miR-581/ZEB2 axis 2022 ·Cellular Signalling ·(unknown), Fei Wang, (unknown), (unknown), (unknown), Xiaoyuan Zheng, Yang Zhou, (unknown), Fang Li, Yingchao Wang, Xiaoyu Yang, Bixing Zhao	5
12	Pien Tze Huang Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells by Repressing PDGFRB/YAP/CCN2 Axis Activity 2022 ·Chinese Journal of Integrative Medicine ·(unknown), Qi Tian, (unknown), Wenhan Liu, Ye Yang, Wei Chen, (unknown), Xiaoyuan Zheng, (unknown), Qiuyu Zhuang, Bixing Zhao, (unknown), Xiaolong Liu, Qin Li, Yingchao Wang	4
13	Magnetically responsive nanoplatform targeting circRNA circ_0058051 inhibits hepatocellular carcinoma progression 2022 ·Drug Delivery and Translational Research ·You Song, Zijin Luo, (unknown), Ming‐Hsun Wu, (unknown), Fei Wang, (unknown), Yingchao Wang, Xiaolong Liu, Jingfeng Liu, Bixing Zhao	16
14	Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma 2021 ·SHILAP Revista de lepidopterología ·(unknown), Yong Yang, Lei He, Yang Zhou, (unknown), Geng Chen, Bixing Zhao, Yingchao Wang, (unknown), Xiaolong Liu	0
15	Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model 2020 ·Stem Cell Research & Therapy ·Naishun Liao, Yingjun Shi, Yingchao Wang, (unknown), Bixing Zhao, Youshi Zheng, Yongyi Zeng, Xiaolong Liu, Jingfeng Liu	34
16	Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis 2019 ·Molecular Therapy — Oncolytics ·Bixing Zhao, Yingchao Wang, (unknown), Kun Ke, Xiaoyuan Zheng, Fei Wang, (unknown), Naishun Liao, Zhixiong Cai, Yingjun Shi, Youshi Zheng, (unknown), Lili Wang, Qin Li, Jingfeng Liu, Aimin Huang, Xiaolong Liu	31
17	Dataset for quantitative phospho-proteomics analysis of a serial hepatoma cell lines with increasing invasion and metastasis potential 2019 ·SHILAP Revista de lepidopterología ·Xiaohua Xing, (unknown), Ying Sun, Kun Ke, Xiuqing Dong, Hui Chen, Xiaolong Liu, Bixing Zhao, Aimin Huang	1
18	Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification 2018 ·Cancer Management and Research ·Kun Ke, Geng Chen, Zhixiong Cai, Yanbing Huang, Bixing Zhao, Yingchao Wang, Naishun Liao, (unknown), Zhenli Li, Jingfeng Liu	19
19	Adipose tissue-derived stem cells ameliorate hyperglycemia, insulin resistance and liver fibrosis in the type 2 diabetic rats 2017 ·Stem Cell Research & Therapy ·Naishun Liao, Youshi Zheng, Haihua Xie, Bixing Zhao, Yongyi Zeng, Xiaolong Liu, Jingfeng Liu	28
20	Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially 2015 ·International Immunopharmacology ·Wenxiu Zhao, Yaping Xu, Jianfeng Xu, Duan Wu, Bixing Zhao, Zhenyu Yin, Xiaomin Wang	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact